NIH-funded study suggests potential to predict peanut allergy immunotherapy outcomes

(NIH/National Institute of Allergy and Infectious Diseases) Oral immunotherapy for peanut allergy induces early, distinct changes in immune T-cell populations that potentially may help researchers determine which people will respond well to the therapy and which immune mechanisms are involved in the response, a new study suggests. The work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted by scientists at Sta...